동물용 성장 촉진제 시장 : 세계 예측(2026-2032년)

The Animal Growth Promoters Market is projected to grow by USD 31.82 billion at a CAGR of 9.15% by 2032.

Animal growth promoters are increasingly central to livestock productivity, feed efficiency, animal health management, and sustainable protein production. The category includes feed additives, probiotics, prebiotics, enzymes, organic acids, phytogenics, hormones where permitted, and non-antibiotic performance enhancers designed to improve weight gain, nutrient utilization, gut health, and overall herd or flock performance. Demand is shaped by rising consumption of meat, milk, eggs, and aquaculture products, alongside pressure to reduce production costs and improve animal welfare. At the same time, regulatory scrutiny of antibiotic growth promoters has accelerated the shift toward residue-free, microbiome-supportive, and science-backed alternatives. Producers, feed manufacturers, veterinarians, and integrators are prioritizing solutions that align performance outcomes with food safety, traceability, antimicrobial resistance mitigation, and sustainability goals. As a result, innovation in animal growth promoters is moving beyond traditional productivity enhancement toward integrated nutritional strategies that support resilient, efficient, and responsible animal production systems.

Transformative Shifts Reshaping the Animal Growth Promoters Landscape

The animal growth promoters landscape is undergoing a structural transition driven by antimicrobial resistance concerns, consumer demand for cleaner-label animal protein, and tighter rules on antibiotic use in feed. Many jurisdictions have restricted or banned antibiotics for growth promotion, encouraging broader adoption of probiotics, prebiotics, enzymes, essential oils, organic acids, and precision nutrition solutions. Livestock producers are also responding to volatility in feed input costs by selecting additives that improve feed conversion ratios and nutrient digestibility. Parallel changes in animal protein supply chains, including greater use of digital farm management, welfare certification, and residue monitoring, are raising expectations for evidence-based product performance. In poultry, swine, ruminants, and aquaculture, the focus is shifting from single-ingredient growth enhancement to multi-functional formulations that support gut integrity, immune modulation, pathogen control, and stress resilience. These shifts are redefining purchasing criteria, with decision-makers increasingly weighing efficacy, regulatory compliance, sustainability credentials, and compatibility with antibiotic-reduction programs.

Cumulative Impact of Artificial Intelligence on Animal Growth Promoters

Artificial intelligence is beginning to influence animal growth promoter development, validation, and deployment across the livestock value chain. AI-enabled feed formulation tools can analyze ingredient quality, animal genetics, growth-stage requirements, environmental conditions, and performance records to recommend more precise additive inclusion strategies. Machine learning models are also being used to evaluate microbiome data, identify correlations between gut microbial populations and growth performance, and support the design of targeted probiotic, enzyme, and phytogenic combinations. On farms, computer vision, connected sensors, automated weighing systems, and predictive analytics help detect deviations in feed intake, weight gain, behavior, and health status, enabling producers to adjust nutrition programs earlier and reduce performance losses. AI can also improve trial design and data interpretation by integrating large datasets from controlled feeding studies, field trials, and production systems. While adoption depends on data quality, interoperability, and producer readiness, AI is strengthening the move from generalized growth promotion to precision livestock nutrition and outcome-based animal health management.

Key Regional Insights Across Asia-Pacific, Europe, North America, Latin America, Africa, and Middle East

Asia-Pacific remains a critical region for animal growth promoters due to dense livestock production, rising protein consumption, and expanding poultry, swine, dairy, and aquaculture systems. Countries across the region are strengthening feed quality standards while producers adopt probiotics, enzymes, organic acids, and phytogenic additives to improve feed efficiency and reduce reliance on antibiotics. Europe is defined by stringent regulatory controls on antibiotic growth promotion, high consumer sensitivity to residues and welfare, and strong adoption of non-antibiotic feed additives supported by scientific substantiation. North America is shaped by advanced integrated livestock systems, strong veterinary oversight, and established demand for antibiotic-free and no-antibiotics-ever production claims, particularly in poultry and swine supply chains. Latin America, led by large-scale beef, poultry, and pork production, emphasizes cost-effective feed conversion, export compliance, and solutions suited to diverse climates and production intensities. Africa presents long-term relevance as commercial livestock and poultry production expands, with emphasis on affordable productivity enhancers, disease resilience, and improved feed utilization across varied production systems. The Middle East is investing in food security, poultry self-sufficiency, dairy modernization, and controlled-environment animal production, creating demand for growth promoters that perform under heat stress, water scarcity, and feed-import dependency.

Key Group Insights Covering NATO, G7, BRICS, European Union, ASEAN, and GCC Markets

NATO member economies span North America and Europe, where food supply resilience, veterinary standards, antimicrobial stewardship, and secure agricultural supply chains reinforce interest in reliable, compliant, and science-backed animal growth promoter technologies. G7 countries generally show strong regulatory oversight, advanced animal nutrition research, well-established veterinary governance, and growing demand for traceable, welfare-aligned, and antibiotic-reduction-compatible productivity solutions. BRICS economies combine high-volume animal protein production and rapidly evolving feed industries, with China, India, Brazil, Russia, and South Africa reflecting diverse needs across intensive poultry, swine, dairy, beef, and aquaculture systems. The European Union has been a benchmark for antibiotic growth promoter restrictions, creating a mature environment for non-antibiotic alternatives, documented efficacy, residue control, and sustainability-linked feed additive innovation. ASEAN markets are influenced by expanding poultry, aquaculture, and swine production, with feed mills increasingly incorporating enzymes, acidifiers, probiotics, and herbal additives to support productivity under humid tropical conditions. The GCC is prioritizing food security and domestic poultry and dairy production, making heat-stress mitigation, feed efficiency, and biosecurity-compatible growth promoter strategies important for producers operating in arid environments.

Key Country Insights for Major Animal Growth Promoter Markets

China is a pivotal animal protein producer and consumer, with policy-driven efforts to reduce antibiotic use in feed and expand modern feed additive adoption across swine, poultry, dairy, and aquaculture. The United States is characterized by highly integrated poultry, swine, beef, and dairy systems, where feed efficiency, antibiotic stewardship, and verified production claims drive additive adoption. Japan emphasizes food safety, traceability, and high-quality animal protein production, while India's dairy leadership and growing poultry and aquaculture sectors create demand for affordable enzymes, probiotics, mineral nutrition, and gut-health solutions suitable for smallholder and commercial systems. Germany, the United Kingdom, and France continue to focus on responsible antimicrobial use, livestock welfare, sustainable farm assurance, and advanced feed science under strict European regulatory expectations. Australia's beef, dairy, poultry, and sheep sectors prioritize productivity, pasture-linked nutrition, heat resilience, and export compliance, while South Korea's intensive livestock systems focus on feed efficiency, disease prevention, and high-standard animal protein supply chains. Italy and Spain, with significant dairy, swine, and poultry operations, are shaped by European regulatory standards and demand for performance-enhancing alternatives to antibiotics. Canada emphasizes animal welfare, food safety, and veterinary-guided antimicrobial use, supporting demand for evidence-based non-antibiotic growth performance solutions. Russia's livestock sector prioritizes domestic production capability and feed efficiency across poultry, pork, and dairy. Brazil's major poultry, pork, and beef industries require scalable growth promoter approaches aligned with export requirements, feed conversion efficiency, and tropical production conditions, while Mexico's poultry, pork, and dairy sectors rely on productivity-enhancing feed strategies that help manage cost pressures and meet domestic protein demand.

Actionable Recommendations for Animal Growth Promoter Industry Leaders

Industry leaders should prioritize science-backed, regulation-ready animal growth promoter portfolios that address feed efficiency, gut health, immunity, and antibiotic reduction without compromising animal welfare or food safety. Product development should focus on multi-functional formulations combining probiotics, prebiotics, enzymes, organic acids, phytogenics, minerals, and precision nutrition approaches validated through species-specific and life-stage-specific trials. Commercial teams should strengthen technical support for producers by linking additive use to measurable outcomes such as feed conversion, daily weight gain, mortality reduction, nutrient digestibility, and production consistency. Regulatory and quality teams should maintain proactive compliance monitoring across regions, especially where rules differ for antibiotics, hormones, feed additives, labeling, and residue limits. Partnerships with feed mills, veterinarians, integrators, and digital livestock platforms can improve field validation and accelerate adoption. Leaders should also invest in supply chain resilience for key active ingredients, transparent sourcing, and sustainability documentation to meet rising buyer expectations for responsible animal protein production.

Research Methodology for Verified Animal Growth Promoter Insights

The research methodology is based on structured secondary research, primary insights from industry stakeholders, and analytical validation across the animal nutrition and livestock production ecosystem. Secondary inputs include publicly available regulatory documents, feed additive guidelines, veterinary antimicrobial-use frameworks, livestock production statistics, scientific literature, food safety standards, and trade-related references from recognized institutions. Primary validation typically involves discussions with feed manufacturers, veterinarians, livestock nutritionists, additive formulators, distributors, producers, and supply chain participants to understand adoption patterns, purchasing criteria, regulatory interpretation, and performance expectations. Analytical review focuses on product types, species applications, regional regulatory conditions, production systems, and technology trends such as precision nutrition and AI-enabled animal monitoring. Findings are cross-checked to avoid unsupported assumptions and to ensure that insights reflect verified industry developments rather than speculative market sizing, share estimates, or forecasts. This approach supports a balanced executive summary grounded in observable evidence, regulatory realities, and practical livestock production dynamics.

Conclusion on the Future of Animal Growth Promoters

Animal growth promoters are evolving from conventional productivity enhancers into integrated tools for sustainable livestock performance, antibiotic stewardship, and food supply resilience. Regulatory restrictions on antibiotic growth promotion, consumer expectations for safe and responsibly produced animal protein, and the economic need for better feed efficiency are accelerating adoption of non-antibiotic and precision nutrition solutions. Regional differences remain significant, with Europe leading stringent compliance models, North America advancing integrated and verified production systems, Asia-Pacific driving volume-based innovation needs, Latin America balancing productivity with export standards, and emerging regions focusing on affordability and resilience. Artificial intelligence and digital farm technologies are deepening the shift toward data-guided additive selection and measurable performance outcomes. Industry participants that combine scientific validation, regulatory agility, producer education, and sustainable sourcing will be best positioned to support the next generation of efficient, healthy, and responsible animal production.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Animal Growth Promoters Market, by Product Type

• 7.1. Introduction
• 7.2. Antibiotics
  • 7.2.1. Aminoglycosides
  • 7.2.2. Macrolides
  • 7.2.3. Penicillins
  • 7.2.4. Tetracyclines
• 7.3. Enzymes
  • 7.3.1. Carbohydrase
  • 7.3.2. Phytase
  • 7.3.3. Protease
• 7.4. Ionophores
• 7.5. Phytogenics
  • 7.5.1. Essential Oils
  • 7.5.2. Herbal Extracts
  • 7.5.3. Spices
• 7.6. Prebiotics
  • 7.6.1. Fructo Oligosaccharides
  • 7.6.2. Galacto Oligosaccharides
  • 7.6.3. Mannan Oligosaccharides
• 7.7. Probiotics
  • 7.7.1. Bacillus
  • 7.7.2. Bifidobacterium
  • 7.7.3. Lactobacillus

8. Animal Growth Promoters Market, by Animal Type

• 8.1. Introduction
• 8.2. Aquatic Animals
• 8.3. Cattle
• 8.4. Poultry
• 8.5. Swine

9. Animal Growth Promoters Market, by Form

• 9.1. Introduction
• 9.2. Granules
• 9.3. Liquid
• 9.4. Pellets
• 9.5. Powder

10. Animal Growth Promoters Market, by Mode Of Administration

• 10.1. Introduction
• 10.2. Feed Additive
• 10.3. Injectable
• 10.4. Water Additive

11. Animal Growth Promoters Market, by Application

• 11.1. Introduction
• 11.2. Disease Prevention
• 11.3. Growth Promotion
• 11.4. Reproduction

12. Animal Growth Promoters Market, by End-user

• 12.1. Introduction
• 12.2. Commercial Livestock Farming
• 12.3. Integrated Poultry Operations
• 12.4. Veterinary Healthcare
• 12.5. Feed Manufacturing Industry

13. Animal Growth Promoters Market, by Distribution

• 13.1. Introduction
• 13.2. Feed Manufacturers
• 13.3. Veterinary Channels
• 13.4. Direct Sales

14. Animal Growth Promoters Market, by Region

• 14.1. Asia-Pacific
• 14.2. Europe
• 14.3. North America
• 14.4. Latin America
• 14.5. Africa
• 14.6. Middle East

15. Animal Growth Promoters Market, by Group

• 15.1. NATO
• 15.2. G7
• 15.3. BRICS
• 15.4. European Union
• 15.5. ASEAN
• 15.6. GCC

16. Animal Growth Promoters Market, by Country

• 16.1. China
• 16.2. United States
• 16.3. Japan
• 16.4. India
• 16.5. Germany
• 16.6. United Kingdom
• 16.7. Australia
• 16.8. France
• 16.9. South Korea
• 16.10. Italy
• 16.11. Canada
• 16.12. Russia
• 16.13. Brazil
• 16.14. Mexico
• 16.15. Spain

17. Competitive Landscape

• 17.1. Market Share Analysis, 2025
• 17.2. FPNV Positioning Matrix, 2025
• 17.3. Market Concentration Analysis, 2025
  • 17.3.1. Concentration Ratio (CR)
  • 17.3.2. Herfindahl Hirschman Index (HHI)
• 17.4. Recent Developments & Impact Analysis, 2025
• 17.5. Product Portfolio Analysis, 2025
• 17.6. Benchmarking Analysis, 2025

18. Company Profiles

• 18.1. Adisseo France SAS
• 18.2. Advanced Enzyme Technologies Limited
• 18.3. Alltech, Inc.
• 18.4. Archer-Daniels-Midland Company
• 18.5. Associated British Foods plc
• 18.6. BASF SE
• 18.7. Boehringer Ingelheim Animal Health GmbH
• 18.8. Cargill, Incorporated
• 18.9. Ceva Sante Animale S.A.
• 18.10. Charoen Pokphand Foods Public Company Limited
• 18.11. DSM-Firmenich AG
• 18.12. DuPont de Nemours, Inc.
• 18.13. Elanco Animal Health Incorporated
• 18.14. Evonik Industries AG
• 18.15. Guangdong Haid Group Co., Ltd.
• 18.16. Huvepharma EOOD
• 18.17. Kemin Industries, Inc.
• 18.18. Lallemand Inc.
• 18.19. Land O'Lakes, Inc.
• 18.20. New Hope Liuhe Co., Ltd.
• 18.21. Novonesis Group
• 18.22. Novus International, Inc.
• 18.23. Nutreco N.V.
• 18.24. Phibro Animal Health Corporation
• 18.25. Vetoquinol S.A.
• 18.26. Virbac S.A.
• 18.27. Zoetis Inc.